Navigation Links
Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
Date:7/14/2011

LA JOLLA, Calif., July 14, 2011 /PRNewswire/ -- Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has added Gregory Hannon, Ph.D. to its Scientific Advisory Board (SAB). The addition of Dr. Hannon, a researcher whose work has involved the molecular identification and characterization of the microRNA pathway, increases SAB membership to six pioneers in this area of scientific research.

"We are delighted to add Greg to our SAB as he brings new insights to the already outstanding group of scientific advisors aiding us in the understanding of microRNA biology," said Neil W. Gibson, Ph.D., chief scientific officer of Regulus. "Greg is a world-renowned researcher with expertise in small regulatory RNAs and an understanding of the molecular mechanisms by which they operate."

"The Regulus SAB includes many of the world's thought leaders in the field of microRNA," said David Baltimore, Ph.D., professor of biology at the California Institute of Technology and Director of Regulus as well as Chairman of Regulus' SAB. "Greg's seminal discoveries in the field of non-coding RNAs include the identification of the enzyme Dicer which cleaves double stranded RNA to produce small RNAs like microRNA. This discovery contributed to Science magazine naming small RNAs the 2002 Breakthrough of the Year."

Dr. Hannon's laboratory has identified and characterized many of the major biogenesis and effector complexes for microRNAs and small interfering RNAs. In addition, the Hannon lab strives to understand the biology of cancer cells, with a focus on the roles of small RNAs as oncogenes and tumor suppressors.

In addition to Dr. Hannon, Regulus' SAB members are:

  • David Baltimore, Ph.D., professor of biology at the California Institute of Technology, member of t
    '/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
(Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014 ... a provider of advanced cancer genome analysis and ... leader in discovering and developing highly selective kinase ... first-ever comprehensive genomic study of malignant mixed Mullerian ... the female reproductive system, also known as carcinosarcoma. ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Delivers Unprecedented Specificity for ... Diagnosing ... Medical Solutions,Diagnostics (http://www.siemens.com/diagnostics ) announced that it has ... rights to develop an,automated stimulating TSH receptor antibody (TRAb) ...
... more effective than,tamoxifen at preventing breast cancer recurrence ... with hormone-responsive cancers. In addition, the increased,risk of ... being treated with,anastrozole disappears after treatment ends., ... Antonio Breast Cancer,Symposium, Professor John Forbes of the ...
Cached Medicine Technology:Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu 2Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu 3Anastrozole Confirmed Superior in Breast Cancer Prevention 2
(Date:9/21/2014)... 21, 2014 C8 lawsuits move forward ... as the list of 20 possible C8 lawsuits ... to six, reports Wright & Schulte LLC. Court records ... almost 2500 C8 lawsuits filed that represent individuals who ... as a result of being exposed to water contaminated ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Recently, iFitDress.com, a ... selection of beautiful party dresses . In addition, the ... the main aim of the promotion is to benefit all ... outfits in its online store now. , Along with ... of graceful items. It has recently released its new sexy ...
(Date:9/20/2014)... 2014 Weight Destroyer , a ... expert Michael Wren that has already helped tens of ... health conditions like high blood pressure, high cholesterol, and ... prompting an investigative review. , “Weight Destroyer is ... down by showing people what is truly effective when ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Villa ... Villa del Palmar Cabo San Lucas, Villa La Estancia ... to Hurricane Odile, with plans to welcome guests back ... As of Sept. 19, all members and guests of ... thanks to a coordinated effort with government authorities. ...
(Date:9/20/2014)... September 20, 2014 Ticket Down ... tickets . This popular ticket exchange is offering their ... , The 2015 schedule of tours is beginning to fill ... announced their plans to hit the road, including 21-year-old pop ... announced the “Honeymoon Tour,” which will take her to 25 ...
Breaking Medicine News(10 mins):Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3
... Permanente has,announced the promotion of Greg Cleary ... as director, Membership,Administration. He joined Kaiser Permanente ... is responsible for overseeing Kaiser Permanente,s,Membership Administration ... Texas. These,locations include more than 800 employees ...
... 15 IDEXX Laboratories,Inc. (Nasdaq: IDXX ), announced ... by the Company of an additional four million,shares of ... will be made in the open market or in ... shares remaining as of,December 31, 2007, under a previous ...
... found, health officials still recommend inoculation , , FRIDAY, Feb. ... in virtually every state, and many of the infections ... this year,s influenza vaccine, U.S. health officials said Friday. ... in the early part of the season, since January, ...
... for TRIA, the first hair removal ... U.S. home-based beauty device market, NEW YORK, Feb. ... Communications as its U.S. agency of record for,TRIA, the ... beauty,device market., SpectraGenics, Inc. is a leader in ...
... leading global,provider of clinical documentation technology and services, ... board of directors., Tsai is a principal ... Co., one of the world,s largest private equity ... hold the,majority ownership of Spheris., Tsai,s election ...
... Beck Says: ,Barack Will Change America, WASHINGTON, ... service workers endorsed Sen. Barack Obama for,president today, ... best plan,and best strategy to lead the country ... the Service Employees International Union endorsed Obama to,achieve ...
Cached Medicine News:Health News:Greg Cleary Named Vice President, Membership Administration for Kaiser Permanente 2Health News:Flu Widespread in U.S., but Vaccine Is Poor Match 2Health News:Spectragenics Names Rpr Marketing Communications Agency of Record 2Health News:Spheris Elects New Board Member 2Health News:SEIU Members Endorse Sen. Barack Obama 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: